SLS SELLAS LIFE SCIENCES GROUP INC Earnings Reports 8-K Filing 2023 - Financial Condition SELLAS Life Sciences Group, Inc. estimates cash and cash equivalents of $17.1 million as of December 31, 2022.Get access to all SEC 8-K filings of the SELLAS LIFE SCIENCES GROUP INC